Skip to main content

BNTX · BioNTech SE

Track BNTX — free
$96.90 +0.05 (+0.05%)
Market Cap
$24.76B
Shares
251.20M
Volume · Oct 1 820.11K Avg daily vol (3M) 1.15M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$96.85 Open$97.59 Day$96.60–99.49 52W close$83.89–119.34 Avg vol 30d1.2M Short int2.3M · 0.9% float · 2.6d Short vol43% Last earningsNov 3, 2026 DataJan 2020–Oct 2026

Up next

Next earnings call
Nov 3, 2026 Scheduled · in 5 wks
call held Mar 10, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+4.3%
Year over year
Operating margin
-49.0%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+4.7%
Year over year · more shares
Price change (1Y)
-0.3%
Trailing year
Short interest
0.9%
Latest settlement · 2.6 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Weak Sentiment Neutral Fundamentals Limited Quant / Vol High
Market backdrop VIX 16.4 · calm Equity put/call 0.57
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −1%
below
Price vs 50-day avg −2%
below
RSI (14) 45
neutral
MACD trend Negative
52-week position 37%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return −7%
trailing
6-month return +1%
trailing
YTD return +2%
this year
Relative strength −11%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $98 › 200d $98 — 50d above 200d
Institutional flow Accumulating
+4% holders QoQ · +42 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.92% of float · ▲ +0.9% MoM · 2.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
286 holders — mid 3-yr range
Squeeze score 50
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
High
Volatility 46%
annualized · 1-yr
Max drawdown −30%
past year
ATR 3.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Sep 30, 2021
Annual effective income tax rate · for the BioNTech group 31%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
1 · 6 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−1% Neutral
Price vs 50-day avg
−2% Neutral
RSI (14)
45 Neutral
MACD trend
Negative Bearish
52-week position
37% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $98 › 200d $98 — 50d above 200d
Institutional flow Accumulating
+4% holders QoQ · +42 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.92% of float · ▲ +0.9% MoM · 2.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
286 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $84 Now $97 · 37% Range high $119
vs 200-day avg -1% vs 50-day avg -2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BNTX
BioNTech SE
this stock
$24.76B +1.7% — — 0.9%
VRTX
Vertex Pharmaceuticals Inc / Ma
$133.37B +11.8% +46.2% 30.7 1.9%
REGN
Regeneron Pharmaceuticals, Inc.
$81.13B -4.8% +20.8% 19.5 2.5%
MRNA
Moderna, Inc.
$79.40B +540.7% +4.3% — 8.2%
CSLLY
Csl Ltd
$61.25B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
286
% held
19.7%
Net QoQ
-359.9K sh
Top holder
FMR LLC
Held Float
View
Held by Funds
Fund positions
142
View
Short & Settlement
Short Interest Rising
Shares short
2.3M
Days to cover
2.6d
Change
+19.9K sh
View
Short Volume
Short vol %
43%
As of
Oct 1, 2026
Short Total
View
Fails to Deliver
FTD shares
1
Value
$102
As of
Sep 2, 2026
View
Off-Exchange
Off-exchange %
43.6%
Week of
Aug 24, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Valerie Hoyle
Amount
$1.0K–$15.0K
Traded
Aug 7, 2025
View
Filings
SEC Filings
Latest
6-K
Filed
Sep 18, 2026
This year
28
View
Proposed Sales
Value
$89.1M
Shares
858.2K
Filed
Sep 3, 2026
View
Exempt Offerings
Offering
$150.0M
Filed
Apr 14, 2022
View
Earnings & Events
Webcasts Upcoming
Next webcast
Nov 3, 2026
Last webcast
Aug 4, 2026
View
Investor Relations
Latest news
BioNTech and OncoC4 Present Updat…
Published
Sep 14, 2026
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
BNTX -2.4% -6.7% +1.4% -1.5% +1.7%
SPY -0.4% -0.2% +12.4% +0.2% +12.0%
vs SPY -2.0% -6.6% -11.0% -1.7% -10.3%
Key facts CIK 1776985 CUSIP 09075V102 13F (30d) 6 filings 6 filers Visit website Investor relations